Clinical analysis of 50 children with juvenile dermatomyositis

REFERENCES

• Cassidy JT, Lindsley CB. Juvenile Dermatomyositis. In: Cassidy IT, Petty RE, editors. Textbook of pediatric rheumatology. 6th ed. Philadelphia: Elsevier Saunder; 2010. p. 375–413.
   Google Scholar
• Spencer-Green G, Schlesinger M, Bove KE, Levinson JE, Sch-aller JG, Hanson V, et al. Nailfold capillary abnormalities in childhood rheumatic diseases. J Pediatr. 1983;102:341–6.
   Google Scholar
• Rider LG, Atkinson JC. Images in clinical medicine. Gingival and periungual vasculopathy of juvenile dermatomyositis. N Engl J Med. 2009;360:e21.
   Google Scholar
• Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P, et al. Medium- and long-term functional outcomes in a mul-ticenter cohort of children with juvenile dermatomyositis. Arthritis Rheum. 2000;43:541–9.
   PubMed Web of Science ®Google Scholar
• Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol. 2002;47:505–11.
   Google Scholar
• Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, et al. Polymyositis—dermatomyositis-asso-ciated interstitial lung disease. Am J Respir Crit Care Med. 2001;164:1182–5.
   PubMed Web of Science ®Google Scholar
• Lee CS, Chen TL, Tzen CY, Lin FJ, Peng MJ, Wu CL, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol. 2002;21:391–6.
   PubMed Web of Science ®Google Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.
   PubMed Web of Science ®Google Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403–7.
   PubMed Web of Science ®Google Scholar
• Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, Pachman LM: NIAMS Juvenile DM RegistryPhysician Referral Group. US incidence of juvenile dermato-myositis. 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 2003;49: 300–5.
   Google Scholar
• Pachman LM, Hayford JR, Hochberg MC, Pallansch MA, Chung A, Daugherty CD, et al. New-onset juvenile dermatomyositis: comparisons with a healthy cohort children with juvenile rheu-matoid arthritis. Arthritis Rheum. 1982;25:126–39.
   PubMedGoogle Scholar
• Fujikawa S, Okuni M. A nationwide surveillance study of rheu-matic diseases among Japanese children. Acta Pediatr Jpn. 1997;39:242–4.
   PubMedGoogle Scholar
• PaIler AS. Juvenile dermatomyositis and overlap syndromes. Adv Dermatol. 1995;10:309–27.
   PubMedGoogle Scholar
• Crowe WE, Bove KE, Levinson JE, Hilton PK. Clinical and pathogenetic implications of histopathology in childhood poly-dermatomyositis. Arthritis Rheum. 1982;25:126–39.
   PubMed Web of Science ®Google Scholar
• Read AM, Pachman LM, Hayford J, Ober C. Immunogenetic studies in families of children with juvenile dermatomyositis. J Rheumatol. 1998;25:1000–2.
   PubMedGoogle Scholar
• Guzman J, Petty RE, Malleson PN. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J Rheumato. 1994;21:739–43.
   Google Scholar
• Bowyer SL, Ragsdale CG, Sullivan DB. Factor VIII related antigen and childhood rheumatic diseases. J Rheumatol. 1989;16: 1093–7.
   Google Scholar
• Bloom BJ, Tucker LB, Miller LC, Schaller JG. Von Willebrand factor in juvenile dermatomyositis. J Rheumatol. 1995;22:320–5.
   PubMed Web of Science ®Google Scholar
• Harden LM, du Plessis I, Poole S, Laburn HP. Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats. Brain Behav Immun. 2008;22:838-49 (Epub 5 Feb 2008).
   Google Scholar
• MacNamara KC, Oduro K, Martin 0, Jones DD, McLaughlin M, Choi K, et al. Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-y signaling. J Immunol. 2011;186:1032-43 (Epub 13 Dec 2010).
   Google Scholar
• Nishikawa T, Hagihara K, Serada S, Isobe T, Matsumura A, Song J, et al. Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression. J Immunol. 2008;180:3492–501.
   PubMed Web of Science ®Google Scholar
• Elst EF, Klein M, de Jager W, Kamphuis S, Wedderburn LR, van der Zee R, et al. Hsp60 in inflamed muscle tissue is the target ofregulatory autoreactive T cells in patients with juvenile dermat-omyositis. Arthritis Rheum. 2008;58: 547–55.
   Google Scholar
• Hiketa T, Ohashi M, Matsumoto Y, Morikawa J, Sasaki R. Ele-vated serum immunoglobulin E levels in patients with juvenile dermatomyositis. J Allergy Clin Immunol. 1992;90:405–7.
   Google Scholar
• Moore EC, Cohen F, Douglas SD, Gutta V. Staphylococcal infections in childhood dermatomyositis-association with the development of calcinosis, raised IgE concentrations and granu-locyte chemotactic defect. Ann Rheum Dis. 1992;51:378–83.
   PubMedGoogle Scholar
• Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010;126:611–7.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Feldman BM. Clinical features and outcome of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am. 2002;28:833–57.
   PubMed Web of Science ®Google Scholar
• Sallum AM, Pivato FC, Doria-Fiho U, Aikawa NE, Liphaus BL, Marie SK, et al. Risk factors associated with calcinosis of juve-nile dermatomyositis. J Pediatr. 2008;84:68–74.
   Google Scholar
• Kim S, El-Gallak M, Degeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP, et al. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. Arthritis Rheum. 2009;60:1825–30.
   PubMedGoogle Scholar
• Huber AM, Lang B, LeB lank CM, Birdi N, Bolaria RK, Malleson P, et al. Medium- and long term functional outcome in a multi-center cohort of children with juvenile dermatomyositis. Arthritis Rheum. 2000;43:541–9.
   PubMed Web of Science ®Google Scholar
• Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A, et al. Childhood Myositis Heterogeneity Study Group : Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Balti-more). 2008;87:70–86.
   PubMed Web of Science ®Google Scholar
• Sanner H, Aalokken TM, Gran JT, Sjaastad I, Johansen B, Flato B. Pulmonary outcome in juvenile dermatomyositis: a case-con-trol study. Ann Rheum Dis. 2011;70:86-91 (Epub 30 Aug 2010).
   Google Scholar
• Parambil JG, Myers JL, Aubry MC, Ryu JH. Causes and prog-nosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest. 2007;132:50-7 (Epub 2 May 2007).
   Google Scholar